产品中心 Products
最新新闻 / News More
1
2019 - 02 - 13
日前,《分子植物》(Molecular Plant)在线发表了中国农业科学院油料作物研究所王汉中院士团队最新成果。该团队在国际上首次成功克隆了农作物种子性状的第一个细胞质调控基因 orf188,并揭示了该基因调控油菜种子高含油量的作用机制。该成果为油菜高含油量育种提供了新途径,为育种过程中杂交母本的选择提供了理论支撑,对于农作物不同类型细胞质的应用具有重要的指导意义。含油量是油菜产油量最重要的构成因子之一,随着现代育种对含油量潜力的不断挖掘,提高品种的含油量越来越困难。该团队在油菜含油量遗传研究的基础上,从细胞质效应着手对含油量母体调控新机制研究取得突破,筛选到两个对含油量具有极显著细胞质正负效应的品种,鉴定出特异基因 orf188 控制细胞质的含油量正效应,过表达该基因可以大幅度提升含油量。研究表明,orf188 为 nap(nap-like)型油菜品种所特有基因,是一个新近进化形成的嵌合基因。该团队十余年来围绕油菜种子性状的母体调控进行系统研究,此次对细胞质基因调控种子含油量机理的揭示,是该团队继发现角果皮发育调控种子粒重和含油量之后发现的又一条母体调控新途径,进一步丰富和完善了种子性状的母体调控理论,也为其他农作物性状细胞质效应的解析提供了借鉴。相关论文信息:DOI:10.1016/j.molp.2019.01.012来源:中国科学报转载:生物360
2
2019 - 06 - 14
随着技术飞速发展、医学数据的持续扩增以及硬件设备的不断提升,人工智能和医疗的结合方式越来越多样化。目前AI在医疗领域中的落地的应用场景主要有医学影像、智能诊疗、智能导诊、智能语音、健康管理、病例分析、医院管理、新药研发和医疗机器人等,其中在医学影像中的应用最为广泛。一、影像医学发展现状医学影像是医生完成诊断的主要依据,通过对影像的分析和比较,从而完成有依据的诊断。但是在实际过程中,往往会存在以下问题:(1)影像学诊断人才资源紧缺。医疗机构普遍缺乏高水平的影像医师,在疾病诊断时往往会发生同病异影,异病同影等情况。(2)传统定性分析存在诊断误差。医生普遍擅长定性分析,很多微小的定量变化无法通过肉眼判断,很难做到定量分析。(3)医生阅片时间长。目前的影像呈现方式为数据和图像,而不是最有效的信息,很大程度上限制了医生的人工阅片速度。二、AI+医学影像助力疾病诊断通过引入人工智能可有效解决部分问题,目前人工智能在医学影像领域的应用方向主要以下几类:1. 影像设备的图像重建AI可以通过算法的图像映射技术,将采集的少量信号恢复出与全采样图像同样质量的图像,而且使用图像重建技术,可以由低剂量的CT和PET图像重建得到高剂量质量图像。这样在满足临床诊断需求的同时,还能够降低辐射的风险。2. 智能辅助诊断疾病(1)智能辅助诊断肺部疾病国内应用AI+CT影像最为成熟的领域在肺结节的识别上。AI能够有效识...
3
2019 - 12 - 25
前瞻记忆是指个体记住未来要完成任务的能力。儿童进入学校后,前瞻记忆任务逐渐增多,对前瞻记忆能力的要求也逐渐增高。前瞻记忆任务成功的关键在于当个体看到线索时能主动提取并执行意图。前瞻记忆线索分为三种,时间线索(如周六晚上7点记得参加朋友的生日聚会)、事件线索(如路过超市记得买水果)和活动结束线索(如写完作业记得找家长签字)。三种线索的提取难度存在差异,这可能与其对注意资源的需求不同有关。较之正常发育的儿童,多动症儿童在日常活动中常有注意力不集中和健忘的表现,提示其前瞻记忆能力可能存在缺损。然而,对多动症儿童前瞻记忆功能的研究较少,更缺乏研究直接考察多动症儿童在三种线索条件下的前瞻记忆表现及其认知加工特点。因此,中国科学院心理研究所心理健康重点实验室神经心理和应用认知神经科学(NACN)实验室陈楚侨研究组与北医六院医生钱英、潍坊医学院教授王艳郁合作考察了多动症儿童在时间、事件和活动结束线索条件下的前瞻记忆表现。该研究招募了28名临床诊断的多动症儿童和28名年龄和性别匹配的正常发育儿童,采用钓鱼游戏任务(Yang, Chan, Shum, 2011)测查儿童在三种线索条件下的前瞻记忆功能。该任务采取经典的双任务范式,主任务要求儿童钓鱼,并同时关注前瞻记忆线索,在线索出现时儿童需要停止钓鱼并执行前瞻记忆任务。在时间线索条件下,儿童要记得每到整分钟就喂猫吃鱼;在事件线索条件下,儿童看到特殊条...
联系我们
北京照生行仪器设备有限公司
电话:021-64396663
邮箱:coco-cs@ulab360.net
地址:上海市浦东新区康桥路787号中天科技商务园5号楼159单元(近康桥路-锦绣路口)
产品名称:

Dynabeads™ CD45

上市日期: 2019-04-17
产品类别: INVITROGEN

Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


  • 产品描述
  • 产品功能
  • 产品参数

Description

Dynabeads® CD45 are superparamagnetic beads covalently coupled to anti-human CD45 antibody that enable isolation or depletion of CD45+ leucocytes directly from whole blood, buffy coat, or MNC suspensions. Dynabeads® CD45 can also be used to enrich epithelial tumor cells. The CD45 antigen is weakly expressed on myeloid cells. To efficiently deplete or isolate all leucocytes including myeloid cells, use Dynabeads® CD15 (Cat. No. 11137D) in combination with Dynabeads® CD45. Advantages of Dynabeads® CD45:

• Efficient depletion of human leucocytes
• Isolation of leucocytes directly from whole blood for molecular applications
• Enrichment of circulating epithelial tumor cells

About Dynabeads® CD45
Dynabeads® CD45 are uniform, superparamagnetic beads (4.5 µm diameter) coated with a primary monoclonal mouse IgG2a antibody specific for a CD45 membrane antigen common to all known isoforms of CD45. CD45 is expressed on all human leucocytes. Because of the bead size, Dynabeads® CD45 can easily and efficiently isolate or deplete cells from viscous samples such as whole blood and bone marrow in about 30 minutes. Dynabeads® CD45 is often used for enrichment of circulating non-hematopoietic tumor cells, by depletion of all CD45+ leucecytes from a MNC sample. Positively isolated cells can be used for downstream molecular studies; for example, those in which cells are to be lysed while still attached to beads, and nucleic acids or proteins further purified. Note that intact cells will not be released from these beads, and we do not recommend to analyze the bead-bound cells with a flow cytometer.

Magnetic bead–based separation offers easy handling
Dynabeads® CD45 is added to the sample under continuous mixing to optimize the binding of the Dynabeads® to the target cells. By placing the sample on a magnet it separates the bead-bound target cells from the rest of the sample in just 1–2 minutes. For depletion, remove the supernatant to a new tube for further studies and discard the bead-bound cells. For positive isolation for molecular studies, remove the supernatant and wash the bead-bound cells 2–3 times in buffer to get optimal purity. The cells can be lysed while still attached to the beads and the supernatant transferred to a new tube for downstream molecular analysis. Starting samples can be whole blood, buffy coat, bone marrow, PBMC, or tissue digests.


Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


Specifications

Capacity:Processes ~5x10^8 cells total
Cell Type:Leukocytes, Tumor Cells
Isolation Method:Depletion, positive isolation for molecular applications
Output Viability:>95%
Product Line:DYNAL®, Dynabeads®
Product Size:5 mL
Sample Type (Specific):Blood, PBMC
Starting Material (Cell #):1x10^7 PBMCs per isolation
Target Species:Human
Shipping Condition:Room Temperature


地址:中国·上海·浦东区-浦东新区康桥路787号5号楼159室
电话:021-64396663
Copyright@ 2015-2016 北京照生行仪器设备有限公司
传真:+86 0755-2788 8009
邮编:330520